Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Kleines and Michael Dreher.
Michael Kleines
Connection Strength
1.462
Michael Dreher
  1. Early risk markers for severe clinical course and fatal outcome in German patients with COVID-19. PLoS One. 2021; 16(1):e0246182.
    View in: PubMed
    Score: 0.232
  2. Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit. J Virol Methods. 2021 02; 288:114024.
    View in: PubMed
    Score: 0.229
  3. Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet. J Virol Methods. 2021 01; 287:113978.
    View in: PubMed
    Score: 0.226
  4. Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis. Eur J Haematol. 2020 Nov; 105(5):655-658.
    View in: PubMed
    Score: 0.223
  5. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG. J Clin Virol. 2020 07; 128:104394.
    View in: PubMed
    Score: 0.220
  6. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. Dtsch Arztebl Int. 2020 04 17; 117(16):271-278.
    View in: PubMed
    Score: 0.219
  7. Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients. Medicine (Baltimore). 2021 Mar 12; 100(10):e24893.
    View in: PubMed
    Score: 0.058
  8. Low-Dose Chest CT for the Diagnosis of COVID-19—A Systematic, Prospective Comparison With PCR Dtsch Arztebl Int. 2020 06 01; 117(22-23):389-395.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.